The central aim of this proposal is to explore the anti-Staphylococcus aureus (S. aureus) activity of endogenous oleic acid (OA), a monounsaturated omega-9 free fatty acid (FFA) naturally existed in humans. The S. aureus bacteria, in particular, methicillin-resistant S. aureus (MRSA), are pathogenic and have a number of virulence factors that enable them to result in disease. They are transmissible and important causes of nosocomial infections worldwide. An MRSA outbreak can occur when one strain is transmitted to other patients or through close contacts of infected persons in the community. Our preliminary results indicated that OA is a biological molecule with bifunctionality: killing MRSA bacteria and enhancing host innate immunity. Here we propose three Specific Aims to (a) investigate the role of endogenous FFA in bacterial killing and host responses to FFA exposures;and (b) develop an FFA-derived new therapeutic against S. aureus/MRSA skin infections.
Three Specific Aims are to (1) Examine the S. aureus strain selectivity of FFAs and investigate the anti-Staphylococcal activity of endogenous FFAs using FFAs-deficient mice;(2) Engineer a Nano-liposome-based FFA (Nano- LipoFFA) specifically targeting S. aureus and explore the bactericidal mechanism of Nano-LipoFFA via physicochemical analysis;and (3) Evaluate the potency of targeted Nano-LipoFFA against S. aureus skin infections and assess the host response to targeted Nano-LipoFFA. To carry out the proposed research, we have formed a solid research team consisting of two bacteriologists (Dr. Chun-Ming Huang, PI;Dr. Richard Gallo, co-investigator), a S. aureus expert (Dr. Victor Nizet, consultant), two nanotechnology engineers (Dr. Mirianas Chachisvilis, co-investigator and Dr. Liangfang Zhang, consultant), and a lipid biologist (Dr. Alan F. Hofmann, consultant). When successful, the results from this proposal will have broad impacts because (a) uncovering the role of endogenous free fatty acids in innate immunity will open a new area of research on host-pathogen interaction;(b) this work may provide a brand new approach to treat MRSA and S. aureus related infections, thereby benefiting the entire community of patients with MRSA infections consisting of over 126,000 patients per year in US;and (c) a similar strategy may potentially be used to treat various infections or diseases caused by other bacteria, thereby benefiting a larger patient community.

Public Health Relevance

S. aureus infection on skin and soft tissue comprises more than 75% of MRSA disease. Treatment of S. aureus/MRSA skin infection using an endogenous oleic acid will be in compliance with evolutionary medicine since the endogenous compound causes a lower risk of developing new drug-resistant S. aureus strains and may have less side effects to patients.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Exploratory/Developmental Grants (R21)
Project #
5R21AI088147-02
Application #
8081826
Study Section
Arthritis, Connective Tissue and Skin Study Section (ACTS)
Program Officer
Huntley, Clayton C
Project Start
2010-06-07
Project End
2013-05-31
Budget Start
2011-06-01
Budget End
2013-05-31
Support Year
2
Fiscal Year
2011
Total Cost
$202,876
Indirect Cost
Name
University of California San Diego
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
804355790
City
La Jolla
State
CA
Country
United States
Zip Code
92093
Liu, Pei-Feng; Wang, Yanhan; Liu, Yu-Tsueng et al. (2017) Vaccination with Killed but Metabolically Active E. coli Over-expressing Hemagglutinin Elicits Neutralizing Antibodies to H1N1 Swine Origin Influenza A Virus. J Nat Sci 3:
Chen, Hui-Wen; Liu, Pei-Feng; Liu, Yu-Tsueng et al. (2016) Nasal commensal Staphylococcus epidermidis counteracts influenza virus. Sci Rep 6:27870
Liu, Pei-Feng; Cheng, Jin-Shiung; Sy, Cheng-Len et al. (2015) IsaB Inhibits Autophagic Flux to Promote Host Transmission of Methicillin-Resistant Staphylococcus aureus. J Invest Dermatol 135:2714-2722
Wang, Y; Dai, A; Huang, S et al. (2014) Propionic acid and its esterified derivative suppress the growth of methicillin-resistant Staphylococcus aureus USA300. Benef Microbes 5:161-8
Wang, Yanhan; Kuo, Sherwin; Shu, Muya et al. (2014) Staphylococcus epidermidis in the human skin microbiome mediates fermentation to inhibit the growth of Propionibacterium acnes: implications of probiotics in acne vulgaris. Appl Microbiol Biotechnol 98:411-24
Shu, Muya; Wang, Yanhan; Yu, Jinghua et al. (2013) Fermentation of Propionibacterium acnes, a commensal bacterium in the human skin microbiome, as skin probiotics against methicillin-resistant Staphylococcus aureus. PLoS One 8:e55380
Wang, Yanhan; Zhu, Wenhong; Shu, Muya et al. (2012) The response of human skin commensal bacteria as a reflection of UV radiation: UV-B decreases porphyrin production. PLoS One 7:e47798
Chen, Chao-Hsuan; Wang, Yanhan; Nakatsuji, Teruaki et al. (2011) An innate bactericidal oleic acid effective against skin infection of methicillin-resistant Staphylococcus aureus: a therapy concordant with evolutionary medicine. J Microbiol Biotechnol 21:391-9
Lo, Chih-Wei; Lai, Yiu-Kay; Liu, Yu-Tsueng et al. (2011) Staphylococcus aureus hijacks a skin commensal to intensify its virulence: immunization targeting ?-hemolysin and CAMP factor. J Invest Dermatol 131:401-9
Huang, Chun-Ming; Chen, Chao-Hsuan; Pornpattananangkul, Dissaya et al. (2011) Eradication of drug resistant Staphylococcus aureus by liposomal oleic acids. Biomaterials 32:214-21

Showing the most recent 10 out of 11 publications